Phagenesis's last reported valuation, Aug 2025. Nothing priced has surfaced since.
- ·The complete investor list: 11 names
- ·Watch Phagenesis: the Monday email on marks, rounds and moves
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
Phagenesis funding history
No funding rounds for Phagenesis are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Phagenesis valuation
Phagenesis's last reported valuation was $51.3 million in Aug 2025. No priced round, secondary trade or fund mark has surfaced since.
How Phagenesis's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Phagenesis, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →
Frequently asked about Phagenesis
- What is Phagenesis worth?
- Phagenesis is valued at $51.3M as of Oct 2026. Phagenesis's last reported valuation, Aug 2025. Nothing priced has surfaced since.
- How much has Phagenesis raised?
- Phagenesis has raised $90.0M in total funding across its recorded rounds.